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SUMMARY
We investigated the role of commensals at the peak
of infection with the colonic mouse pathogen Citro-
bacter rodentium. Bioluminescent and kanamycin
(Kan)-resistant C. rodentium persisted avirulently in
the cecal lumen of mice continuously treated with
Kan. A single Kan treatment was sufficient to
displace C. rodentium from the colonic mucosa,
a phenomenon not observed following treatment
with vancomycin (Van) or metronidazole (Met). Kan,
Van, and Met induce distinct dysbiosis, suggesting
C. rodentium relies on specific commensals for
colonic colonization. Expression of the master viru-
lence regulator ler is induced in germ-free mice, yet
C. rodentium is only seen in the cecal lumen. More-
over, in conventional mice, a single Kan treatment
was sufficient to displaceC. rodentium constitutively
expressing Ler from the colonic mucosa. These re-
sults show that expression of virulence genes is not
sufficient for colonization of the colonic mucosa
and that commensals are essential for a physiolog-
ical infection course.
INTRODUCTION
Antibiotic chemotherapy is often an effective treatment for
bacterial infections, leading to a rapid reduction in bacterial
burden, morbidity, and mortality. However, unintentional tar-
gets of oral antibiotics are commensal bacteria, which provide
a protective barrier against pathogens (Kamada et al., 2013;
Zhang et al., 2013). Antibiotic-induced dysbiosis increases
host susceptibility to bacterial colonization; by pre-treating
mice with streptomycin pathogenic and non-pathogenic bac-
teria, e.g., Salmonella enterica serovar Typhimurium and
Escherichia coli, can colonize the murine gastrointestinal tract,
which is usually refractory to these strains (Barthel et al., 2003;
Spees et al., 2013). However, little attention has been paid
to the consequences of antibiotic treatment during physiolog-
ical enteric infections, which occur in the context of the
endogenous microbiota, and the impact of antibiotic treat-
ment on host physiology (e.g., streptomycin causes cecal
enlargement).
Citrobacter rodentium is an extracellular enteric murine path-
ogen that shares an infection strategy and virulence factors
with the human diarrheagenic pathogens enteropathogenic
and enterohemorrhagic E. coli (EPEC and EHEC) (Collins
et al., 2014). In C57BL/6 mice, C. rodentium causes a self-
limiting infection, without the need for antibiotic pre-treatment,
and triggers robust colitis, colonic crypt hyperplasia (CCH), and
dysbiosis (Collins et al., 2014). Following oral inoculation,
C. rodentium colonizes the cecum, where the pathogen adapts
to the in vivo environment of the gut and from where it spreads
to the distal colon and undergoes rapid expansion (Wiles et al.,
2004). Colonization of C. rodentium plateaus 6 or 7 days post-
infection (DPI) and starts to clear 10–12 DPI (Collins et al., 2013;
Wiles et al., 2004). C. rodentium colonizes the colonic mucosa
while forming attaching and effacing (A/E) lesions, which are
characterized by effacement of the brush border microvilli un-
derneath attached bacteria (Collins et al., 2014). Infection of
cultured cells with C. rodentium leads to the formation of
actin-rich pedestal-like structures (Collins et al., 2014; Crepin
et al., 2010). The ability to form A/E lesions and pedestals is
conferred by the locus of enterocyte effacement (LEE) pathoge-
nicity island (McDaniel et al., 1995), which encodes the tran-
scriptional regulators Ler (Mellies et al., 1999), GrlA, and GrlR
(Deng et al., 2004); the adhesin intimin; a type III secretion sys-
tem (T3SS); and effectors (Garmendia et al., 2005; Wong et al.,
2011). Mutants in ler, in which the LEE is not expressed, are
avirulent, yet they can colonize germ-free mice (Kamada
et al., 2012).
The gut microbiota is known to have a significant impact on
C. rodentium disease course. Transplantation of the gut micro-
biota from C57BL/6 mice to lethally susceptible C3H/HeOuJ
mice prevented mortality (Ghosh et al., 2011); Bacteroides the-
taiotaomicron influences C. rodentium virulence gene expres-
sion via alteration of the metabolic landscape (Curtis et al.,
2014), and gut commensals are necessary for effective clear-
ance of luminal C. rodentium following infection (Kamada et al.,
2012).
In this study, we used the bioluminescent (BL) and kanamycin
(Kan)-resistant C. rodentium strain ICC180 and antibiotic treat-
ment to test the effect of disrupting commensal bacteria during
the peak of an acute enteric infection.
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RESULTS
Treating ICC180 Infection with Kan Leads to Bacterial
Persistence
We determined the impact of disturbing the microbiota with daily
oral treatments of C57BL/6mice with Kan (1,000mg/kg/day) dur-
ing the acute phase of ICC180 infection, from 6 DPI; ICC180 is
resistant to >500 mg/mL Kan in vitro (not shown). Treatments
with ciprofloxacin (Cip) (100 mg/kg/day) and water were used as
controls. Enumeration of bacterial shedding and in vivo biolumi-
nescent imaging (BLI) revealed that the water-treated group fol-
lowed typical clearance dynamics and Cip-treated mice cleared
C. rodentium within 48 hr (Figures 1A and 1B). In contrast, daily
oral treatments with Kan resulted in the number of shed
C. rodentium plateauing at around 109 colony-forming units
Figure 1. Kan Treatment during
C. rodentium Infection Triggers AIBP and
Prevents Colonic Colonization
Mice infected withC. rodentium were treated daily
with Kan (1,000 mg/kg), Cip (100 mg/kg), or water
from 6 DPI.
(A) Quantification of C. rodentium CFUs in
stool from 6 to 37 DPI. Mean values ± SEM;
n = 5–6 mice.
(B) In vivo BLI of C. rodentium from representative
mice, showing a redistribution of the BL signal
from the colon to the cecum.
(C) Quantification of C. rodentium CFUs in stool,
following discontinuation of Kan treatment at
15 DPI, demonstrating AIBP is a transient state.
Mean values ± SEM; n = 3 mice.
(D) In vivo BLI of C. rodentium from representative
mice prior to treatment (at 6 DPI) and one day
post-Kan treatment. See also Figure S1.
(E) Ex vivo BLI of the cecal tissue and contents and
colonic tissue 1 day post a single 1,000mg/kg Kan
treatment (7 DPI) from representative mice. Bright
BL signal is seen in the cecal contents whereas
little signal is observed on the cecal and colonic
mucosa of the Kan-treated mice.
(CFUs)/g of feces for the duration of the
study (Figure 1A), a phenomenon we
term antibiotic-induced bacterial persis-
tence (AIBP). Stopping the Kan treatment
resulted in rapid clearance of the infection
(Figure 1C), suggesting the AIBP state is
transient. BLI revealed that AIBP was
accompanied by redistribution of the BL
signal from the colon and cecum prior to
Kan treatment to solely the cecum post-
treatment (Figure 1B).
Investigating the kinetics of AIBP
induction revealed that a single Kan treat-
ment was sufficient to cause redistribu-
tion of the BL signal from the colon
to the cecum (Figures 1D and 1E).
Characterization of the dose-dependent
response to Kan showed that, following
a single treatment with 500 mg/kg, all mice exhibited cecal BL
(Figure S1A). In contrast, following a single treatment with
250 mg/kg, this occurred in only 50% of the mice, whereas in
the water-treated controls, BL remained visible in the colon of
all animals (Figure S1A);C. rodentium shedding was comparable
in all groups (Figure S1B). Ex vivo BLI showed that, following a
single Kan treatment, C. rodentium is confined to the cecum,
specifically the luminal cecal contents, with no BL signal visible
on the distal colon (Figure 1E).
C. rodentium in the AIBP State Is Avirulent
We next examined the infectivity of C. rodentium after 20 Kan
treatments (26 DPI) by co-housing mice harboring AIBP
C. rodentiumwith naive untreated mice; untreated mice infected
with C. rodentium for 7 days were used as a control. Whereas
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mice co-housed with control animals developed a robust colonic
infection by 4 days post-co-habitation, those co-housed with the
AIBP donor did not (Figure 2A). Further, AIBPC. rodentium taken
directly from re-suspended feces was unable to adhere to
cultured mouse fibroblasts, whereas C. rodentium from control
animals readily triggered pedestal formation (Figure 2B). Pas-
sage of AIBP C. rodentium in lysogeny broth (LB) prior to infec-
tion restored pedestal formation (not shown). Taken together,
these data suggest a reversible repression of virulence gene
expression in AIBP C. rodentium.
To directly visualize virulence gene expression in the AIBP
state, we infected mice with a reporter C. rodentium strain
(ICC690), in which a chromosomal lux operon is under the control
of the ler promoter. A strain containing a single base pair deletion
in the ler promoter (position30; Figure S2A), rendering the pro-
Figure 2. C. rodentium in the AIBP State Are
Non-infectious
(A) In vivo BLI of control and AIBP-donor mice and
co-housed naive untreated recipient mice at 2, 4,
and 7 days post co-habitation (DPC), showing
AIBP C. rodentium is not transmissible.
(B) Scanning electron microscopy of mouse fi-
broblasts infected with C. rodentium isolated
from feces of control or AIBP mice. Control
C. rodentium, but not AIBP C. rodentium, are able
to induce pedestal formation. Images are at a
magnification of 3,0003; scale bar, 5 mm.
(C) Quantification of C. rodentium CFUs in stools
of mice infected with ICC690 (Pler-lux) or ICC1370
(Pler*(constitutive)-lux) and treated with Kan
(500 mg/kg/day). Mean values ± SEM; n = 5 mice.
(D) In vivo BLI of representative mice, showing
dimming of the ICC690 BL signal over time,
demonstrating ler downregulation in the AIBP
state.
See also Figure S2.
moter constitutively active (Islam et al.,
2011), was used as a control (ICC1370;
Figure S2B). Following oral inoculation,
both ICC690 and ICC1370 were shed at
comparable numbers (Figure 2C). A sin-
gle dose of Kan resulted in redistribution
of the BL of ICC690 and ICC1370 from
the colon to the cecum. Whereas the BL
signal in ICC690 diminished following
4 daily Kan treatments (10 DPI) and re-
mained dim (Figure 2D), the BL signal re-
mained visible in the cecum of ICC1370-
infectedmice at 24 DPI (Figure 2D). These
results show that expression of ler, and
by extension expression of the LEE, is
downregulated in the AIBP state.
Kan-Induced Disruption of the
Microbiota Displaces Colonic
C. rodentium
Despite colonizing the colonic mucosa
at 6 DPI, prior to antibiotic treatment,
little to no BL signal was observed on the distal colon following
a single dose, suggesting that Kan treatment displaces colonic
C. rodentium (Figure 1E). To confirm that the lack of BL
reflects an absence of mucosal-attached C. rodentium, the tis-
sue-associated colonic CFUs of Kan-treated (1,000 mg/kg)
mice were determined; water-treated mice were used as a con-
trol. Comparable levels of ICC180 were shed in the stool of
both groups (Figure 3A); however, whereas significantly more
C. rodentium were found in the cecal content, significantly
fewer ICC180 were present in the distal colon of the Kan-
treated, compared to the water-treated, mice (Figure 3B).
Immunofluorescence staining of C. rodentium further confirmed
that little to no C. rodentium was present on the colonic mu-
cosa following a single Kan treatment (Figure 3C). As CCH
and elevated fecal Lipocalin-2 (LCN-2) are known markers of
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C. rodentium infection (Collins et al., 2014; unpublished data),
we investigated whether these parameters were impacted by
a single Kan treatment. No significant differences in CCH or
fecal LCN-2 were observed after a single Kan treatment
compared to water-treated controls or mice prior to treatment,
respectively (Figures 3D and 3E).
Met and Van Treatments Do Not Induce AIBP
To test whether the inability to colonize the colonic mucosa is the
result of the specific depletion of Kan-sensitive commensals or a
general reduction in microbiotal diversity, we tested the effect of
two other classes of antibiotics that C. rodentium resists:
vancomycin (Van) (50 mg/kg/day) and metronidazole (Met)
(100 mg/kg/day). Kan, Van, and Met induced distinct taxonomic
changes to the fecal microbiota (Figure 4A) and caused a signif-
icant reduction in alpha diversity (Figure 4B). BLI showed that,
following Van or Met treatments, ICC180 remained visible on
the colonic mucosa (Figure 4C). Therefore, the depletion of
commensals by a single Kan treatment, but not Van or Met
treatments, displaces C. rodentium from the colonic mucosa.
Antibiotic-treatedanimalshave reducedgutmotilityanddisplay
enlarged ceca (Wostmann and Bruckner-Kardoss, 1960). How-
ever, measuring the gut transit times of antibiotic-treated mice
showed no significant reduction after a single treatment with
Kan, Van, or Met compared to water-treated controls (Figure 4D),
suggesting this is not related to the inability of C. rodentium to
colonize the colonic mucosa following Kan treatment.
The Role of Ler Expression in C. rodentium Colonic
Colonization during Kan Treatment
Members of the gut microbiota have been shown to indirectly
modulate EHEC and C. rodentium virulence gene expression
(Curtis et al., 2014). Therefore, to investigate whether the inability
of C. rodentium to colonize the colonic mucosa of Kan-treated
mice is due to repression of ler, we deleted the negative regulator
GrlR from ICC180 to generate ICC1410, which constitutively ex-
presses ler (Lio and Syu, 2004). ICC1410 hyper-secretes translo-
cators and effectors in non-ler-inducing conditions (Figure 5A)
and infects cultured cells more robustly than ICC180 (Figure 5B).
Following infections of conventional mice, ICC1410 behaved
similarly to ICC180 and colonized the colonic mucosa at 6 DPI
(Figures 5C and 5D). Importantly, following a single Kan dose,
the BL signal was found exclusively in the cecal content (Fig-
ure 5D), demonstrating ler downregulation does not account
for the inability of ICC180 to colonize the colonic mucosa
following Kan treatment.
C. rodentium Colonizes the Cecal Lumen of Germ-
free Mice
As disruption of the microbiota affects the ability of C. rodentium
to colonize the colonic mucosa, we next investigated the
outcome of infection of germ-free mice with ICC690 and
ICC1370. CFU enumeration showed that, similarly to Kan-
treated mice and consistent with previous data (Kamada et al.,
2012), germ-free mice persistently shed C. rodentium at high
titers (Figure 5E). Whereas the BL signal in ICC690-infected
mice was dim 2 DPI and bright 8 DPI, a diminishing signal was
seen at 12 and 14 DPI (Figure 5F). A bright signal from the control
ICC1370 was seen at 14 DPI (Figure 5F), with similar CFUs to
ICC690 shed in the stool (Figure 5E). These results suggest
that cues from the host can upregulate ler gene expression
during early C. rodentium infection in vivo. Importantly, despite
strong ler expression at 8 DPI, ex vivo BLI and CFU enumeration
revealed C. rodentium primarily reside in the cecal content
Figure 3. Kan Treatment Displaces
C. rodentium from the Colonic Mucosa
ICC180-infected mice were given a single Kan
(1,000 mg/kg) or water treatment at 6 DPI and
harvested 24 hr later.
(A) Quantification of C. rodentium CFUs in the
stool.
(B)Quantification of tissue-associatedC. rodentium
CFUs, revealing significantly elevated bacterial load
in the cecal contents and decreased CFUs in the
distal colons of Kan-treated mice. (A) and (B) show
mean values ± SEM; n = 4 mice. Significance was
determined by an unpaired two-tailed Student’s
t test.
(C) Indirect immunofluorescence of sections
of 0.5 cm distal colon, showing little to no
C. rodentium present on the Kan-treated colon.
C. rodentium staining is in red, E-cadherin in green,
and DNA in blue. The scale bar represents 200 mm.
(D) Colonic crypt lengths of 0.5-cm distal colon.
Eachdatapoint represents themeancrypt lengthof
a single mouse. (B and D) Significance was deter-
mined by an unpaired two-tailed Student’s t test.
(E) Stool LCN-2 concentrations of the same mice
at 6 DPI (untreated; 0 DPT) and 1 day following a
single Kan treatment (1 DPT). Each dot represents
a single mouse. Significance was determined by a
paired two-tailed Student’s t test. *p < 0.05; ns,
not significant.
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Figure 4. Vancomycin and Metronidazole Do Not Prohibit Colonic Colonization
(A and B) 16S RNA sequencing analysis of stools collected from uninfected mice prior to antibiotic treatment (T0) and 24 hr after 3 daily treatments of Kan
(1,000mg/kg/day), Van, Met, or a water control (T3). (A) The relative abundance of taxa is shown. (B) Alpha diversity of the species in each of the treatment groups
after T0 and T3 is shown. Significance was determined by a paired two-tailed Student’s t test.
(C) In vivo and ex vivo BLI of ICC180-infected mice treated with Van or Met, showing C. rodentium remain associated with the colonic mucosa.
(D) Total gut transit time of uninfected mice 24 hr following a single Kan (1,000 mg/kg), Van, Met, or water treatment, showing no significant differences in gut
motility. Significance was determined by a one-way ANOVA with Tukey’s multiple comparison post-test. **p < 0.01; ***p < 0.001; ****p < 0.0001.
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(Figures 5F and 5G). Taken together, these results demonstrate
that C. rodentium virulence gene expression alone is not suffi-
cient for effective colonic mucosal colonization and that it is
reliant on members of the gut microbiota for a physiological
infection course.
DISCUSSION
Commensal bacteria are one of the first barriers of defense
against invading pathogens at mucosal surfaces (Kamada et al.,
2013). In this study, we investigated the role of commensals dur-
ing the peak of enteric infection.Weused the naturalmouse path-
ogenC. rodentium, which can effectively colonize and trigger A/E
lesions on the colonic mucosa, without antibiotic pre-treatment
and in the presence of the endogenous microbiota. We show
Figure 5. Expression of Virulence Genes Is
Not Sufficient for Colonic Colonization
(A) Coomassie staining and the corresponding
western blot (EspA and EspB) of bacterial culture
supernatants, demonstrating constitutive T3S in
ICC1410.
(B) Indirect immuno-fluorescence staining of
representative HeLa cells infected with ICC180 or
ICC1410. In right-hand panels, actin staining is in
red, C. rodentium in cyan, and DNA in white.
(C and D) Mice infected with C. rodentium DgrlR
(ICC1410) were given a single Kan (1,000 mg/kg)
treatment at 6 DPI. (C) Quantification of
C. rodentium CFUs in the stool is shown.
Mean ± SEM; n = 3 mice. (D) In vivo BLI at 6 DPI
(pre-treatment) and 24 hr post-Kan treatment and
corresponding ex vivo BLI of excised organs is
shown, demonstrating bright BL in the cecal
content and diminished mucosal BL signal
following infection withC. rodentium constitutively
expressing the LEE.
(E–G) Germ–free C57BL/6 mice were infected with
the Pler-lux reporter stain ICC690 or the Pler*(con-
stitutive)-lux control strain ICC1370. (E) Quantifi-
cation of C. rodentium CFUs in the stool is shown.
Mean ± SEM; n = 3–5 mice. (F) Representative
ex vivo BLI of excised organs is shown, demon-
strating confinement of the BL signal to the
cecal contents, despite strong ler expression
at 8 DPI. (G) Quantification of tissue-associated
C. rodentium CFUs is shown.
that antibiotic-induced dysbiosis with
daily treatments of Kan gives rise to an
avirulent population that persists in the
lumen of the cecumand severely depletes
the tissue-associated colonic population.
Pre-treatment of mice with antibiotics
has been used to facilitate colonization
of the mouse gut with S. Typhimurium
(Barthel et al., 2003) and EHEC (Wadol-
kowski et al., 1990); however, this leads
to habitation of the cecal lumen. We
confirmed that, in the absence of the
microbiota (i.e., in germ-free mice),
C. rodentium mainly inhabits the cecal lumen, persisting at
high titers avirulently (Kamada et al., 2012). We show that a
persistent avirulent cecal population can also be induced with
Kan treatment. Following humoral immunity-mediated eradica-
tion of virulent bacteria, commensal Proteobacteria are able
to compete with C. rodentium for monosaccharides, effectively
eliminating avirulent luminal C. rodentium (Kamada et al.,
2012). Interestingly, we found Kan treatment results in a signifi-
cant overgrowth of Bacteroidetes, primarily the Bacteroides
and Parabacteroides genera. Members of the Bacteroidetes
phylum, such as B. thetaiotaomicron and Bacteroides vulgatus,
which can utilize both mono- and poly-saccharides, are ineffec-
tive at out-competing avirulent C. rodentium (Kamada et al.,
2012). Together, this may explain the ability of C. rodentium to
persist in mice following Kan treatment.
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C. rodentium infection is associated with overgrowth of
Enterobacteriaceae (Lupp et al., 2007), and we have recently
shown that, during the peak of C. rodentium infection, elevated
levels of gut cholesterol and mucosal O2 cause a bloom in
mucosal-associated g-proteobacteria (Berger et al. 2017).
Here, we show that the presence of gut commensals is
required for colonization of the colonic mucosa; disruption of
the microbiota with Kan leads to the rapid displacement of
colonic tissue-associated C. rodentium. This phenomenon
occurs when the microbiota is disrupted following intimate
C. rodentium attachment and colonic A/E lesion formation.
Met and Van treatment did not displace C. rodentium after
four daily treatments; indeed, Met treatment has previously
been found to exacerbate C. rodentium-induced colitis as a
result of increased microbiotal degradation of the protective
mucus layer (Wlodarska et al., 2011). Therefore, specific
changes to the microbiome, induced by some antibiotic formu-
lations, but not others, rather than a general reduction in diver-
sity, displaces colonic C. rodentium.
Virulence of A/E pathogens is dependent on expression of LEE
genes, which is regulated by a plethora of external stimuli,
includingmicrobiota-derivedmetabolites. Short-chain fatty acids
(SCFAs), including succinate and butyrate, andmucin O-glycans,
derived fromdegradation of gutmucans by commensals, such as
B. thetaiotaomicron, all serve as regulators of the EHEC and
C. rodentium T3SS (Curtis et al., 2014; Nakanishi et al., 2009; Pa-
checo et al., 2012). However, interestingly, similar to wild-type
C. rodentium, we observed displacement ofC. rodentium consti-
tutively expressing ler from the colon following a single Kan treat-
ment, demonstrating that this phenomenon occurs via a mecha-
nism independent of Ler modulation. Therefore, our data show
that, under conditions of specific dysbiosis, expression of viru-
lence factors enablingA/E lesion formation is not sufficient for effi-
cient colonization of the colonic mucosa. In germ-free mice, we
observed a dramatic increase in ler gene expression between 2
and 8 DPI, which then decreased by 14 DPI, likely due to the reg-
ulatory feedback loop in which Ler inhibits its own transcription
(Berdichevsky et al., 2005). This further demonstrates that the
inability ofC. rodentium to colonize the cecal and colonicmucosa
in germ-free mice 8 DPI, when Ler is highly expressed, is not due
to repression of virulence genes. Moreover, these findings sug-
gest that host cues alone are able to control ler gene induction
in C. rodentium colonizing germ-free mice.
Our data suggest that, during the peak of infection, rather than
acting as a barrier for colonization, the gut microbiota are to
some extent necessary to maintain colonic tissue-associated
C. rodentium and, by extension, other enteric pathogens
(e.g., EHEC and EPEC) via a mechanism independent of viru-
lence gene modulation. Enteric pathogens, such as Clostridium
difficile and S. Typhimurium, are reported to utilize microbiota-
derived energy sources, including salic acid and fucose
(Ng et al., 2013). S. Typhimurium exploits tetrathionate, a prod-
uct of the reaction of reactive oxygen species (ROS) with micro-
biota-produced hydrogen sulfide as an alternative electron
acceptor (Winter et al., 2010). It is interesting to note that the in-
crease in gut cholesterol at 8 DPI is accompanied by a high level
of cholesterol-metabolizing Proteobacteria, including Serratia,
Dickeya, and Erwinia (Berger et al., 2017).C. rodentium is unable
to grow on cholesterol as the sole carbon source; however, it
is capable of utilizing degradation products, such as succinate
(unpublished data), and it is interesting to speculate that
C. rodentium may rely on other members of the microbiota to
provide an energy source at the nutrient-poor epithelium. More-
over, depletion of butyrate-producing commensals by broad-
spectrum antibiotics alters intestinal epithelial cell metabolism,
resulting in increased luminal O2 (Kelly et al., 2015; Rivera-Cha´-
vez et al., 2016). This would be expected to be beneficial
to C. rodentium, which relies on aerobic respiration at the gut
mucosa (Lopez et al., 2016). Indeed, we have recently shown
that, during C. rodentium infection, the effector Map disrupts
the mitochondrial function of intestinal epithelial cells to increase
mucosal oxygenation (Berger et al., 2017). However, it is
possible that an ‘‘over’’ saturation of O2 in the gut mucosa
(as a combined result of infection and antibiotic treatment)
may be detrimental to C. rodentium, for example, by facilitating
enhanced ROS production.
The fact that enteric pathogens may rely on commensals for
colonization of mucosal surfaces emphasizes the importance
of studying infection and pathogen–microbiome–host interac-
tions at physiological anatomic sites in the gut within the context
of the endogenous microbiota. Further work is required to fully
elucidate the exact timescale and nature of dysbiosis induced
following a single Kan treatment and the mechanism by which
this excludes C. rodentium from the colonic mucosa.
EXPERIMENTAL PROCEDURES
Bacterial Strain Construction and Infections
C. rodentium strains were constructed by standard cloning methods. Western
blot verification of strain phenotypes and cell culture infections were
performed using standard techniques; see Supplemental Experimental Pro-
cedures and Tables S1 and S2.
Treatment of Mice with Antibiotics and Infection Studies
All animal experiments complied with the Animals Scientific Procedures Act
1986 and UK Home Office guidelines and were approved by the local ethical
review committee. Experiments were designed in agreement with the
ARRIVE guidelines (Kilkenny et al., 2010) for the reporting and execution of
animal experiments, including sample randomization and blinding. Mouse
experiments were performed with 3–8 mice/group and repeated on at least
two separate occasions, with the exception of Figures S1 and 4A, which
were performed once. Pathogen-free female 18–20 g C57BL/6 mice (Charles
River Laboratories) were housed in high-efficiency particulate air (HEPA)-
filtered cages with sterile bedding and given food and water ad libitum.
Mice were infected with C. rodentium by oral gavage as described (Crepin
et al., 2016). From 6 DPI, mice were gavaged with Cip (100 mg/kg/day in
water), Kan (250–1,000 mg/kg/day in water), Van (50 mg/kg/day in water),
Met (100 mg/kg/day in 5 mM HCl), or sterile water. For microbiome
sequencing, naive, uninfected mice were gavaged with antibiotics; stools
were collected prior to treatment and 24 hr after 3 daily treatments and
immediately flash frozen.
Germ-free Mice
All germ-free animal studies were approved by the Weizmann Institute of
Science Institutional Animal Care and Use Committee (IACUC), application
number 28050616. Germ-free mice were born in the Weizmann Institute
germ-free facility and routinely monitored for sterility; on the day of inoculation,
germ-free mice were transferred into sterile iso-cages (Hecht et al., 2014).
Germ-free mice were given a regular chow diet ad libitum and infected with
C. rodentium as described above.
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Co-housing Experiments
An AIBP donor mouse (26 DPI with ICC180; post-20 Kan 1,000 mg/kg/day
treatments) was co-housed with naive, untreated recipient mice. As a control,
an untreated, ICC180-infected mouse (7 DPI) was separately co-housed with
naive mice. In both cases, the donor mice were removed after 72 hr.
In Vivo Optical Imaging of C. rodentium-Infected Mice
Whole-animalbioluminescence imaging (BLI)wasperformedusingan IVISSpec-
trum CT (PerkinElmer; Crepin et al., 2016). At necropsy on the days indicated,
excised gastrointestinal tissues with the mucosa exteriorized were also imaged.
Sample Processing and Histological Analysis
Colonization was monitored by enumeration of viable bacteria (CFU) per gram
of feces or tissue as indicated. Histological analysis (CCHmeasurements) and
immuno-staining were performed as described (Crepin et al., 2016); see
Supplemental Experimental Procedures.
Measurement of Gut Transit Times
Mice were given a single antibiotic dose, as described above. 24 hr later, mice
were gavaged with 300 mL 6% (w/v) carmine red in 0.5% (w/v) methyl cellulose
solution. Mice were housed in individual cages and given food and water
ad libitum. Total gut transit was recorded as the time from gavage until the
passage of the first red stool rounded up to the nearest 10 min.
LCN-2 Measurement
Stool samples were homogenized in PBS + 0.1% Tween-20. Samples were
centrifuged at 16,000 rpm for 10min and the supernatant extracted and stored
at 80C. LCN-2 concentration was determined using a DuoSet Mouse
Lipocalin-2/NGAL ELISA (R&D Systems), according to the manufacturer’s
instructions.
16S Sequencing and Analysis
Stool samples were processed for DNA isolation using MoBio (PowerSoil kit)
according to the manufacturer’s instructions. The purified DNA from feces
was used for PCR amplification and sequencing of the bacterial 16S rRNA
gene. Amplicons of 380 base pairs spanning the variable region 3 or 4
(V3–4) of the 16S rRNA gene were generated by using designated primers.
The PCR products were subsequently pooled in an equimolar ratio, purified
(PCR clean kit; Promega), and used for Illumina MiSeq sequencing. Reads
were processed using the QIIME (quantitative insights into microbial ecology)
analysis pipeline as previously described (Elinav et al., 2011) version 1.8.
Paired-end joined sequences were grouped into operational taxonomic units
(OTUs) using the UCLUST algorithm and the GreenGenes database (DeSantis
et al., 2006). Sequences with distance-based similarity of 97% or greater over
median sequence length of 353 base pairs were assigned to the same OTU.
Analysis was performed at each taxonomical level (phylum to genus and spe-
cies level if possible) separately. For each taxon, statistical tests were per-
formed between the different groups. p values were false discovery rate
(FDR) corrected for multiple hypothesis testing.
Statistical Analyses
Data were analyzed by a paired or unpaired two-tailed Student’s t test or one-
way ANOVA with Tukey’s multiple comparison post-test, as specified in figure
legends. A commercially available software (GraphPad 7) was used; a p value
of <0.05 was taken to be significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
two figures, and two tables and can be found with this article online at
https://doi.org/10.1016/j.celrep.2017.11.086.
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